Skip to main content
SpringerLink
Log in

Tumor necrosis factor-α and ceramides in insulin resistance

  • Lipids And Insulin Resistance
  • Published:
Lipids

Abstract

The present studies tested the hypothesis that some effects of tumor necrosis factor-α (TNF-α) are mediated by activation of sphingomyelinases and the production of ceramides. Differentiated 3T3-L1 adipocytes were incubated with short-chain ceramide analogs, (C2- and C6-ceramides:N-acetyl- andN-hexanoyl-sphingosines, respectively), and this treatment increased 2-deoxyglucose uptake in the absence of insulin progressively from 2–24 h. This effect was inhibited by blocking the activations of mitogen-activated protein kinase, phosphatidylinositol 3-kinase (PI 3-kinase), and ribosomal S6 kinase which mediated an increase in GLUT1 concentrations. Long-term increases in PI 3-kinase activity associated with insulin receptor substrate-1 (IRS-1) increased the proportion of GLUT1 and GLUT4 in plasma membranes. These events explain the increases in noninsulin-dependent glucose uptake and incorporation of this glucose into the fatty acid and glycerol moieties of triacylglycerol. The mechanisms by which TNF-α and ceramides increase PI 3-kinase activity were investigated further by using rat2 fibroblasts. Incubation for 20 min with TNF-α, bacterial sphingomyelinase, or C2-ceramides increased PI 3-kinase activity by about fivefold, and this effect depended upon a stimulation of tyrosine kinase activity and an increase in Ras-GTP. This demonstrates the existence of a novel signaling pathway for TNF-α that could contribute to the effects of this cytokine in stimulating basal glucose uptake. By contrast, treating the 3T3-L1 adipocytes for 2–24 h with C2-ceramide diminished insulin-stimulated glucose uptake by decreasing the insulin-induced translocation of GLUT1 and GLUT4 to plasma membranes. This inhibition was observed when there was no increase in basal glucose uptake, and it occurred downstream of PI 3-kinase. Our work provides further mechanisms whereby TNF-α and ceramides produce insulin resistance and decrease the effectiveness of insulin in stimulating glucose disposal from the blood. Conversely, TNF-α and ceramides increase the ability of adipocytes to take up glucose and store triacylglycerol in the absence of insulin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

C2−:

acetyl−

C6−:

hexanoyl

DMEM:

Dulbecco’s minimum essential medium

GLUT4:

glucose transporter 4

IRS-1:

insulin receptor substrate-1

PI 3-kinase:

phosphatidylinositol 3-kinase

TNF-α:

tumor necrosis factor-α

References

  1. Kahn, C.R. (1994) Insulin Action, Diabetogenes, and the Cause of Type II Diabetes,Diabetes 43, 1066–1084.

    PubMed  CAS  Google Scholar 

  2. Hotamisligil, G.S., and Spiegelman, B.M. (1994) Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link,Diabetes 43, 1271–1278.

    PubMed  CAS  Google Scholar 

  3. Hotamisligil, G.S., Budavari, A., Murray, D., and Spiegelman, B.M. (1994) Reduced Tyrosine Kinase Activity of the Insulin Receptor in Obesity-Diabetes,J. Clin. Invest. 94, 1543–1549.

    Article  PubMed  CAS  Google Scholar 

  4. Hotamisligil, G.S., Murray, D.L., Choy, L.N., and Spiegelman, B.M. (1994) Tumor Necrosis Factor α Inhibits Signaling from the Insulin Receptor,Proc. Natl. Acad. Sci. USA 91, 4854–4858.

    Article  PubMed  CAS  Google Scholar 

  5. Feinstein, R., Kanety, H., Papa, M.Z., Lunenfeld, B., and Karasik, A. (1993) Tumor Necrosis Factor-α Suppresses Insulin-Induced Tyrosine Phosphorylation of Insulin Receptor and Its Substrates,J. Biol. Chem. 268, 26055–26058.

    PubMed  CAS  Google Scholar 

  6. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., and Spiegelman, B.M. (1995) IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α and Obesity-Induced Insulin Resistance,Science 271, 665–668.

    Article  Google Scholar 

  7. Kanety, H., Feinstein, R., Papa, M.Z., Hemi, R., and Karasik, A. (1995) Tumor Necrosis Factor α-Induced Phosphorylation of Insulin Receptor Substrate-1 (IRS-1),J. Biol. Chem. 270, 23780–23784.

    Article  PubMed  CAS  Google Scholar 

  8. Guo, D., and Donner, D.B. (1996) Tumor Necrosis Factor Promotes Phosphorylation and Binding of Insulin Receptor Substrate 1 to Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes,J. Biol. Chem. 271, 615–618.

    Article  PubMed  CAS  Google Scholar 

  9. Stephens, J.M., Lee, J., and Pilch, P.F. (1997) Tumor Necrosis Factor-α-Induced Insulin Resistance in 3T3-L1 Adipocytes Is Accompanied by a Loss of Insulin Receptor Substrate-1 and GLUT4 Expression Without a Loss of Insulin Receptor-Mediated Signal Transduction,J. Biol. Chem. 272, 971–976.

    Article  PubMed  CAS  Google Scholar 

  10. Hannun, Y.A. (1994) The Sphingomyelin Cycle and the Second Messenger Function of Ceramide,J. Biol. Chem. 269, 3125–3128.

    PubMed  CAS  Google Scholar 

  11. Peraldi, P., Hotamisligil, G.S., Burman, W.A., White, M.F., and Spiegelman, B.M. (1996) Tumor Necrosis Factor (TNF)-α Inhibits Insulin Signaling Through Stimulation of the P55 TNF Receptor and Activation of Sphingomyelinase,J. Biol. Chem. 271, 13018–13022.

    Article  PubMed  CAS  Google Scholar 

  12. Kanety, H., Hemi, R., Papa, M.Z., and Karasik, A. (1996) Sphingomyelinase and Ceramide Suppress Insulin-Induced Tyrosine Phosphorylation of the Insulin Receptor Substrate-1,J. Biol. Chem. 271, 9895–9897.

    Article  PubMed  CAS  Google Scholar 

  13. Begum, N., and Ragolia, L. (1996) Effect of Tumor Necrosis Factor-alpha on Insulin Action in Cultured Rat Skeletal Muscle Cells,Endocrinology 137, 2441–2446.

    Article  PubMed  CAS  Google Scholar 

  14. Wang, C.-N., O’Brien, L., and Brindley, D.N. (1998) Effects of Cell-Permeable Ceramides and Tumor Necrosis Factor-α on Insulin Signaling and Glucose Uptake in 3T3-L1 Adipocytes,Diabetes 47, 24–31.

    PubMed  CAS  Google Scholar 

  15. Hanna, A.N., Chan, E.Y.W., Xu, J., Stone, J.C., and Brindley, D.N. (1999) A Novel Pathway for Tumor Necrosis Factor-α and Ceramide Signaling Involving Sequential Activation of Tyrosine Kinase, p21RAS, and Phosphatidylinositol 3-Kinase,J. Biol. Chem. 274, 12722–12728.

    Article  PubMed  CAS  Google Scholar 

  16. Hausdorff, S.F., Frangioni, J.V., and Birnbaum, M.J. (1994) Role of p21ras in Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes,J. Biol. Chem. 269, 21391–21394

    PubMed  CAS  Google Scholar 

  17. Taha, C., Mitsumoto, Y., Liu, Z., Skolnik, E.Y., and Klip, A. (1995) The Insulin-Dependent Biosynthesis of GLUT1 and GLUT3 Glucose Transporters in L6 Muscle Cells Is Mediated by Distinct Pathways,J. Biol. Chem. 270, 24678–24681.

    Article  PubMed  CAS  Google Scholar 

  18. Szalkowski, D., White-Carrington, S., Berger, J., and Zhang, B. (1995) Antidiabetic Thiazolidinediones Block the Inhibitory Effect of Tumor Necrosis Factor-α on Differentiation, Insulin-Stimulated Glucose Uptake, and Gene Expression in 3T3-L1 Cells,Endocrinology 136, 1474–14781.

    Article  PubMed  CAS  Google Scholar 

  19. Cornelius, P., Marlowe, M., Lee, M.D., and Pekala, P.H. (1990) The Growth Factor-Like Effects of Tumor Necrosis Factor-Alpha. Stimulation of Glucose Transporter Activity and Induction of Glucose Transporter and Immediate Early Gene Expression in 3T3-L1 Preadipocytes,J. Biol. Chem. 265, 20506–20516.

    PubMed  CAS  Google Scholar 

  20. McGowan, K.M., Police, S., Winslow, J.B., and Pekala, P.H. (1997) Tumor Necrosis Factor α Regulation of Glucose Transporter (GLUT1) mRNA Turnover,J. Biol. Chem. 272, 1331–1337.

    Article  PubMed  CAS  Google Scholar 

  21. Evans, D.A., Jacobs, D.O., and Wilmore, D.W. (1989) Tumor Necrosis Factor Enhances Glucose Uptake by Peripheral Tissues,Am. J. Physiol. 257, R1182-R1189

    PubMed  CAS  Google Scholar 

  22. Marette, A., Atgié, C., Liu, Z., Bukowiecki, U.J., and Klip, A. (1993) Differential Regulation of GLUT1 and GLUT4 Glucose Transporters in Skeletal Muscle of a New Model of Type II Diabetes,Diabetes 42, 1195–2001.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry (Signal Transduction Laboratories), University of Alberta, T6G 2S2, Edmonton, Alberta, Canada

    David N. Brindley, Chuen-Neu Wang, Jie Mei, James Xu & Atef N. Hanna

Authors
  1. David N. Brindley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chuen-Neu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jie Mei
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Atef N. Hanna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David N. Brindley.

About this article

Cite this article

Brindley, D.N., Wang, CN., Mei, J. et al. Tumor necrosis factor-α and ceramides in insulin resistance. Lipids 34 (Suppl 1), S85–S88 (1999). https://doi.org/10.1007/BF02562240

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02562240

Keywords

Search

Navigation